First-year treatment costs among new initiators of topical prostaglandin analogs

References

• SchwartzGFQuigleyHAAdherence and persistence with glaucoma therapySurv Ophthalmol200853Suppl 1S57S6819038625
   PubMed Web of Science ®Google Scholar
• FriedmanDSHahnSRGelbLDoctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency StudyOphthalmology20081158132013271327.e1318321582
   PubMed Web of Science ®Google Scholar
• NordstromBLFriedmanDSMozaffariEQuigleyHAWalkerAMPersistence and adherence with topical glaucoma therapyAm J Ophthalmol2005140459860616226511
   PubMed Web of Science ®Google Scholar
• SitAJWeinrebRNCrowstonJGKripkeDFLiuJHSustained effect of travoprost on diurnal and nocturnal intraocular pressureAm J Ophthalmol200614161131113316765686
   PubMed Web of Science ®Google Scholar
• CostagliolaCDel PreteAVerolinoMEffect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patientsGraefes Arch Clin Exp Ophthalmol2002240537938612073061
   PubMed Web of Science ®Google Scholar
• NetlandPALandryTSullivanEKTravoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionAm J Ophthalmol2001132447248411589866
   PubMed Web of Science ®Google Scholar
• RobinALCovertDDoes adjunctive glaucoma therapy affect adherence to the initial primary therapy?Ophthalmology2005112586386815878067
   PubMed Web of Science ®Google Scholar
• NeelakantanAVaishnavHDIyerSASherwoodMBIs addition of a third or fourth antiglaucoma medication effective?J Glaucoma200413213013615097258
   PubMed Web of Science ®Google Scholar
• SchmierJKCovertDWRobinALEstimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspectiveCurr Med Res Opin200723112867287517922980
   PubMed Web of Science ®Google Scholar
• SchmierJKCovertDWRobinALFirst-year treatment patterns among new initiators of topical prostaglandin analogsCurr Med Res Opin200925485185819231912
   PubMed Web of Science ®Google Scholar
• BaudouinCDetrimental effect of preservatives in eyedrops: implications for the treatment of glaucomaActa Ophthalmol200886771672618537937
   PubMed Web of Science ®Google Scholar
• HorsleyMBKahookMYEffects of prostaglandin analog therapy on the ocular surface of glaucoma patientsClin Ophthalmol2009329129519668581
   PubMedGoogle Scholar
• HenryJCPeaceJHStewartJAStewartWCEfficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapyClin Ophthalmol20082361362119668762
   PubMedGoogle Scholar
• KahookMYNoeckerRJComparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tearsCornea200827333934318362664
   PubMed Web of Science ®Google Scholar
• LeungEWMedeirosFAWeinrebRNPrevalence of ocular surface disease in glaucoma patientsJ Glaucoma2008817535035518703943
   PubMed Web of Science ®Google Scholar
• GrossRLPeaceJHSmithSEDuration of IOP reduction with travoprost BAK-free solutionJ Glaucoma200817321722218414108
   PubMed Web of Science ®Google Scholar
• LewisRAKatzGJWeissMJTravoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacyJ Glaucoma20071619810317224758
   PubMed Web of Science ®Google Scholar
• American Academy of OphthalmologyPreferred Practice Pattern. Primary Open-Angle Glaucoma. Limited RevisionSan Francisco, CAAmerican Academy of Ophthalmology2003
   Google Scholar
• FremontAMLeePPMangioneCMPatterns of care for open-angle glaucoma in managed careArch Ophthalmol2003121677778312796247
   PubMedGoogle Scholar
• QuigleyHAFriedmanDSHahnSREvaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency StudyOphthalmology200711491599160617572498
   PubMed Web of Science ®Google Scholar
• Thomson HealthcareRed Book Drug TopicsMontvale, NJThomson Healthcare2008
   Google Scholar
• Practice Management Information CorporationMedical Fees in the United StatesLos Angeles, CAPractice Management Information Corporation2008
   Google Scholar
• FiscellaRGGreenAPatuszynskiDHWilenskyJMedical therapy cost considerations for glaucomaAm J Ophthalmol20031361182512834665
   PubMed Web of Science ®Google Scholar
• FriedmanDSQuigleyHAGelbLUsing pharmacy claims data to study adherence to glaucoma medications: methodology and find-ings of the Glaucoma Adherence and Persistency Study (GAPS)Invest Ophthalmol Vis Sci200748115052505717962457
   PubMed Web of Science ®Google Scholar
• SpoonerJJBullanoMFIkedaLIRates of discontinuation and change of glaucoma therapy in a managed care settingAm J Manag Care2002810 SupplS262S27012188169
   PubMed Web of Science ®Google Scholar
• BrownMMBrownGCSpaethGLImproper topical self-administration of ocular medication among patients with glaucomaCan J Ophthalmol1984191256608974
   PubMed Web of Science ®Google Scholar
• StoneJLRobinALNovackGDCovertDWCagleGDAn objective evaluation of eyedrop instillation in patients with glaucomaArch Ophthalmol2009127673273619506189
   PubMedGoogle Scholar
• AshburnFSJrGoldbergIKassMACompliance with ocular therapySurv Ophthalmol19802442372486987764
   PubMed Web of Science ®Google Scholar
• KholdebarinRCampbellRJJinYPBuysYMMulticenter study of compliance and drop administration in glaucomaCan J Ophthalmol20084345446118711461
   PubMed Web of Science ®Google Scholar
• NorellSEGranstromPASelf-medication with pilocarpine among out-patients in a glaucoma clinicBr J Ophthalmol19806421371417362816
   PubMed Web of Science ®Google Scholar
• TsaiTRobinALSmithJP3rdAn evaluation of how glaucoma patients use topical medications: a pilot studyTrans Am Ophthalmol Soc20071052933discussion 25–33.18427591
   PubMedGoogle Scholar
• EsquenaziSCystoid macular edema in a pseudophakic patient after switching from latanoprost to BAK-free travoprostJ Ocul Pharmacol Ther200723656757018001244
   PubMed Web of Science ®Google Scholar
• CarrilloMMNicolelaMTCystoid macular edema in a low-risk patient after switching from latanoprost to bimatoprostAm J Ophthalmol2004137596696815126179
   PubMed Web of Science ®Google Scholar
• MoroiSEGottfredsdottirMSSchteingartMTCystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertensionOphthalmology199910651024102910328408
   PubMed Web of Science ®Google Scholar
• CallananDFellmanRLSavageJALatanoprost-associated cystoid macular edemaAm J Ophthalmol199812611341359683162
   PubMed Web of Science ®Google Scholar
• FriedmanDSWolfsRCO’ColmainBJPrevalence of open-angle glaucoma among adults in the United StatesArch Ophthalmol2004122453253815078671
   PubMedGoogle Scholar
• SchwartzGFReardonGMozaffariEPersistency with latanoprost or timolol in primary open-angle glaucoma suspectsAm J Ophthalmol20041371 SupplS13S1614697910
   PubMed Web of Science ®Google Scholar